Search research articles
Contact Us
Filters
Showing results (91-100 of 204) with videos related to
Page
of 21
Sort By:
Inflammatory Bowel Diseases
|
November 25, 2022
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease
Emily C L Wong, Parambir S Dulai, John K Marshall, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Impact of Concomitant Corticosteroid Use on Adverse Events in Ulcerative Colitis Clinical Trials
Hasan Hamam, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases
|
December 30, 2021
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab
Parambir S Dulai, Emily C L Wong, Walter Reinisch, et al.
Inflammatory Bowel Diseases
|
June 24, 2022
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials
Rocio Sedano, Malcolm Hogan, Guangyong Zou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 30, 2021
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
Neeraj Narula, Emily C L Wong, John K Marshall, et al.
Journal of Crohn'S & Colitis
|
March 11, 2021
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Journal of Crohn'S & Colitis
|
September 15, 2020
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Alimentary Pharmacology & Therapeutics
|
June 6, 2019
Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease
Adam Tepler, Neeraj Narula, Richard M Peek, et al.
European Journal of Gastroenterology & Hepatology
|
August 17, 2021
Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patients
Tomer Greener, Karen Boland, Raquel Milgrom, et al.
Crohn'S & Colitis 360
|
October 28, 2024
Interventions for Adjunctive Care in Patients With Inflammatory Bowel Disease and Permanent Ileostomy: A Systematic Review
Sudheer Kumar Vuyyuru, Virginia Solitano, Yuhong Yuan, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 204) with videos related to
Sort By:
Page
of 21
Inflammatory Bowel Diseases
|
November 25, 2022
Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease
Emily C L Wong, Parambir S Dulai, John K Marshall, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Impact of Concomitant Corticosteroid Use on Adverse Events in Ulcerative Colitis Clinical Trials
Hasan Hamam, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases
|
December 30, 2021
Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab
Parambir S Dulai, Emily C L Wong, Walter Reinisch, et al.
Inflammatory Bowel Diseases
|
June 24, 2022
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials
Rocio Sedano, Malcolm Hogan, Guangyong Zou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 30, 2021
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
Neeraj Narula, Emily C L Wong, John K Marshall, et al.
Journal of Crohn'S & Colitis
|
March 11, 2021
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Journal of Crohn'S & Colitis
|
September 15, 2020
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials
Neeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Alimentary Pharmacology & Therapeutics
|
June 6, 2019
Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease
Adam Tepler, Neeraj Narula, Richard M Peek, et al.
European Journal of Gastroenterology & Hepatology
|
August 17, 2021
Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patients
Tomer Greener, Karen Boland, Raquel Milgrom, et al.
Crohn'S & Colitis 360
|
October 28, 2024
Interventions for Adjunctive Care in Patients With Inflammatory Bowel Disease and Permanent Ileostomy: A Systematic Review
Sudheer Kumar Vuyyuru, Virginia Solitano, Yuhong Yuan, et al.
Page
of 21